We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
-$5.16B
Cap. Flow
-$7.02B
Cap. Flow %
-4.43%
Top 10 Hldgs %
22.66%
Holding
961
New
80
Increased
260
Reduced
443
Closed
63

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.18B
2
HOLX
Hologic
HOLX
+$1.14B
3
CI icon
Cigna
CI
+$1.05B
4
ROP icon
Roper Technologies
ROP
+$918M
5
DTE icon
DTE Energy
DTE
+$834M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 20.04%
3 Consumer Discretionary 13.58%
4 Financials 12.54%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLR icon
926
Icon
ICLR
$12.8B
-60,669
Closed -$10.6M
INSP icon
927
Inspire Medical Systems
INSP
$1.68B
-4
Closed -$1K
IOVA icon
928
Iovance Biotherapeutics
IOVA
$2.99B
-12,638
Closed -$28K
IVT icon
929
InvenTrust Properties
IVT
$2.62B
-66
Closed -$2K
LAMR icon
930
Lamar Advertising Co
LAMR
$15.9B
-24
Closed -$3K
LIVN icon
931
LivaNova
LIVN
$4.5B
-29
Closed -$2K
LMB icon
932
Limbach Holdings
LMB
$533M
-305,556
Closed -$29.7M
LRCX icon
933
Lam Research
LRCX
$415B
-8,005
Closed -$1.07M
LZB icon
934
La-Z-Boy
LZB
$1.67B
-86
Closed -$3K
MGNI icon
935
Magnite
MGNI
$3.52B
-890,918
Closed -$19.4M
MP icon
936
MP Materials
MP
$9.81B
-52,791
Closed -$3.54M
MRC
937
DELISTED
MRC Global
MRC
-897,476
Closed -$12.9M
MRUS
938
DELISTED
Merus
MRUS
-51
Closed -$5K
MTN icon
939
Vail Resorts
MTN
$5.24B
-21,047
Closed -$3.15M
NMRA icon
940
Neumora Therapeutics
NMRA
$315M
-1,938,100
Closed -$3.53M
NSP icon
941
Insperity
NSP
$1.99B
-50
Closed -$3K
NVST icon
942
Envista
NVST
$4.63B
-101
Closed -$3K
NWSA icon
943
News Corp Class A
NWSA
$15.7B
-170
Closed -$6K
OPEN icon
944
Opendoor
OPEN
$3.4B
-548,661
Closed -$4.23M
PECO icon
945
Phillips Edison & Co
PECO
$5.2B
-49
Closed -$2K
PNC icon
946
PNC Financial Services
PNC
$103B
-56,477
Closed -$11.3M
QURE icon
947
uniQure
QURE
$3.11B
-977
Closed -$58K
REGN icon
948
Regeneron Pharmaceuticals
REGN
$83.2B
-435
Closed -$245K
RNAM
949
DELISTED
Avidity Biosciences
RNAM
-1,401,906
Closed -$61.1M
RXST icon
950
RxSight
RXST
$289M
-416
Closed -$4K

Similar funds

T. Rowe Price Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, T. Rowe Price Investment Management held 961 positions worth $158B, down 3.2% from $164B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

T. Rowe Price Investment Management withdrew a net $7.02B in Q4 2025, closing 63 positions and reducing 443 holdings. Its most notable exit was Bright Horizons, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Investment Management opened a new position in Keurig Dr Pepper worth $728M.

  • T. Rowe Price Investment Management's largest Q4 2025 buy was Keurig Dr Pepper: 25,978,817 shares worth $728M.
  • T. Rowe Price Investment Management added most to Cencora in Q4 2025, an estimated $1.41B increase.
  • T. Rowe Price Investment Management's biggest Q4 2025 reduction was Danaher, cutting an estimated $1.18B.
  • T. Rowe Price Investment Management fully exited Bright Horizons in Q4 2025, selling an estimated $240M.
  • T. Rowe Price Investment Management's ten largest holdings make up 23% of its $158B portfolio in Q4 2025.
  • T. Rowe Price Investment Management opened 80 new positions and closed 63 in Q4 2025.
  • T. Rowe Price Investment Management's portfolio value fell 3.2% quarter-over-quarter to $158B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.